Jain Vivek, Chairman and CEO, has demonstrated a clear pattern of insider trading activity focused exclusively on ICU Medical, Inc. (ICUI), as evidenced by 32 SEC Form 4 filings. Over time, Vivek has executed transactions totaling $15,081,239.14 in purchases and $24,652,680.95 in sales, indicating a net selling bias. Recent activity reinforces this trend, with two buys and one sell in March 2026. Notably, on March 8, 2026, Vivek sold shares valued at $7,854,000, marking the largest single transaction in the dataset. Earlier transactions include significant sales, such as $2,207,761.48 and $266,613.04 in August 2025, and $213,474.04 in January 2025. Purchases, while less frequent, include notable acquisitions like $1,189,534.20 and $338,914.05 in March 2026, as well as $1,115,869.32 in March 2024. The data suggests a consistent focus on ICUI, with a tendency toward divestment over accumulation in recent years. This pattern aligns with Vivek’s role as a key executive, though the filings do not provide context for the transactions beyond their execution.
AI-assisted summary